Paper Review Records
全部论文审稿周期
24 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
235
天
Epitranscriptomic Regulation of PIK3R2 by WTAP/YTHDF3 Axis Drives Nasopharyngeal Carcinoma Progression
作者
Yilong Xu; Yanyu Xu; Yongqin Chen; Shaorong Lin; Yaxue Liu; Sihai Dai; Mingyan Hong展开收起
作者单位
1. Department of Otorhinolaryngology Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province China; 2. Department of Otolaryngology‐Head and Neck Surgery Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province China展开收起
190
天
Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer
作者
Xinxing Li; Xin Yang; Lin Zhu; Junyong Weng; Zezhi Shan; Zhiqian Hu; Ariela Samantha; Io Nam Wong; Xinxiang Li展开收起
作者单位
1. Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China; 2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China; 3. Department of General Surgery, Tongji Hospital, School of Medicine Tongji University Shanghai China; 4. Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope, Biomedical Research Center Monrovia California USA; 5. Proteomics Division, Mochtar Riady Institute for Nanotechnology Universitas Pelita Harapan Tangerang Banten Indonesia; 6. Department of Biology Universitas Pelita Harapan Tangerang Banten Indonesia; 7. Faculty of Medicine, Macau University of Science and Technology Macau China; 8. AI Cross Disciplinary Research Institute, Macau University of Science and Technology Macau China; 9. Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine Macau University of Science and Technology Macau China; 10. Zhuhai MUST Science and Technology Research Institute/Macau University of Science and Technology Innovation Technology Research Institute Hengqin China展开收起
324
天
Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS ‐Induced Colitis via Mucus Barrier Protection
作者
Marcela S. C. Brito; Anderson K. Taporosky; Katlin S. Rech; Lucas B. S. Santos; Marcelo B. Gois; Larissa F. N. de Souza; Rilton A. de Freitas; Carolina A. B. Azevedo; Carolina Mathias; Lucimara M. C. Cordeiro; Maria F. P. Werner展开收起
作者单位
1. Pharmacology Department Federal University of Paraná Curitiba Paraná Brazil; 2. Biochemistry and Molecular Biology Department Federal University of Paraná Curitiba Paraná Brazil; 3. Faculty of Health Sciences of the Federal University of Rondonópolis Rondonópolis Mato Grosso Brazil; 4. BioPol, Pharmacy Department Federal University of Paraná Curitiba Paraná Brazil; 5. Genetic Department Federal University of Paraná Curitiba Paraná Brazil展开收起
151
天
KRIT1 Inhibits TGF ‐β/Smad‐Mediated Endothelial‐To‐Mesenchymal Transition in Pulmonary Arterial Hypertension
作者
Debin Ma; Liang Shi; Congcong Li; Di Song; Lei Liu展开收起
作者单位
1. Department of Respiratory and Critical Care Medicine General Hospital of Northern Theater Command Shenyang China展开收起
103
天
Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K /Akt/ mTOR Pathway in Triple‐Negative Breast Cancer
作者
Tong Sha; Jingjing Fan; Xiaoli Wang; Binlin Ma展开收起
作者单位
1. Department of Breast Thyroid Surgery, Xinjiang Medical University Affiliated Tumor Hospital The Clinical Medical Research Center of Breast and Thyroid Tumors in Xinjiang Urumqi China展开收起
105
天
Mechanistic Study of SRSF1 ‐Mediated Inhibition of Treg Cell Function via the mTORC1 / ULK1 Signalling Axis Through Mitophagy in Asthma
作者
Chunhua Ye; Yifu Chen; Qinjun Yi; Zhu Ming; Tuoyu Gan; Rong Xiang展开收起
作者单位
1. Department of Emergency Changsha Hospital for Maternal & Child Health Care Changsha Hunan China; 2. Department of Urology The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University(Hunan Children's Hospital) Changsha Hunan China; 3. Department of Pediatrics Changsha Hospital for Maternal & Child Health Care Changsha Hunan China展开收起
FAQ
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY审稿要多久?
截至2026-11-17,CrushSCI 收录了 CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 的 24 篇完整审稿记录。最快一篇从收稿到录用用了 62 天(18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway,2026-07-01 收稿,2026-09-01 录用),最慢一篇用了 575 天;平均 165.3 天,中位数 109.5 天。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
